Safety and tolerability of atomoxetine in treatment of attention deficit hyperactivity disorder in adult patients: An integrated analysis of 15 clinical trials

Meta-Analysis of Suicide-Related Behavior or Ideation in Child, Adolescent, and Adult Patients Treated with Atomoxetine

(2014) Mark E. Bangs et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Practitioner Review: Current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents

(2013) Samuele Cortese et al.   JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY

A review of the abuse potential assessment of atomoxetine: a nonstimulant medication for attention-deficit/hyperactivity disorder

(2013) Himanshu P. Upadhyaya et al.   PSYCHOPHARMACOLOGY

Effects of atomoxetine on the QT interval in healthy CYP2D6 poor metabolizers

(2012) Corina Loghin et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Atomoxetine Treatment Outcomes in Adolescents and Young Adults With Attention-Deficit/Hyperactivity Disorder: Results From a Post Hoc, Pooled Analysis

(2012) Lenard A. Adler et al.   CLINICAL THERAPEUTICS

Risk of Serious Cardiovascular Problems with Medications for Attention-Deficit Hyperactivity Disorder

(2012) Jose Martinez-Raga et al.   CNS DRUGS

Atomoxetine Treatment of Attention-Deficit/Hyperactivity Disorder in Young Adults With Assessment of Functional Outcomes

(2012) Todd M. Durell et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Completed suicide, ideation and attempt in attention deficit hyperactivity disorder

(2011) M. Impey et al.   ACTA PSYCHIATRICA SCANDINAVICA

Clinical and Statistical Assessment of Suicidal Ideation and Behavior in Pharmaceutical Trials

(2011) C Gassmann-Mayer et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults

(2011) Laurel A. Habel et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Stimulants and Cardiovascular Events in Youth With Attention-Deficit/Hyperactivity Disorder

(2011) Mark Olfson et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD

(2010) Sandra JJ Kooij et al.   BMC Psychiatry

Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis

(2009) Viktória Simon et al.   BRITISH JOURNAL OF PSYCHIATRY

Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder

(2009) Lenard A. Adler et al.   DEPRESSION AND ANXIETY

How do different diagnostic criteria, age and gender affect the prevalence of attention deficit hyperactivity disorder in adults? An epidemiological study in a Hungarian community sample

(2009) István Bitter et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Once-Daily Atomoxetine for Adult Attention-Deficit/Hyperactivity Disorder

(2009) Lenard A. Adler et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Atomoxetine and Cerebrovascular Outcomes in Adults

(2009) Crystal N. Holick et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Meta-Analysis of Suicide-Related Behavior Events in Patients Treated With Atomoxetine

(2009) MARK E. BANGS et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

Abuse liability assessment of atomoxetine in a drug-abusing population

(2008) Donald R. Jasinski et al.   DRUG AND ALCOHOL DEPENDENCE

Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders

(2008) Timothy E. Wilens et al.   DRUG AND ALCOHOL DEPENDENCE

Long-Term, Open-Label Safety and Efficacy of Atomoxetine in Adults With ADHD

(2008) Lenard A. Adler et al.   Journal of Attention Disorders

The prevalence and effects of adult attention-deficit/hyperactivity disorder (ADHD) on the performance of workers: results from the WHO World Mental Health Survey Initiative

(2008) R de Graaf et al.   OCCUPATIONAL AND ENVIRONMENTAL MEDICINE